Dr. Kinsella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
110 Lockwood St
Suite 130
Providence, RI 02903Phone+1 401-444-8402Fax+1 401-444-7002- Is this information wrong?
Summary
- Dr. Timothy Kinsella is a radiation oncologist in Providence, RI and is affiliated with multiple hospitals in the area, including Emma Pendleton Bradley Hospital, Miriam Hospital, Newport Hospital, Rhode Island Hospital, and Women & Infants Hospital of Rhode Island. He is a Research Scholar Professor in Radiation Oncology at the Warren Al;pert School of Medicine of Brown University. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 46 years. He is board certified in Internal Medicine (trained at the Mayo Clinic), Medical oncology (trained at Dana Farber Cancer Center in Boston) and in Radiation Oncology ( trained at the Harvard Joint Center for Radiation Therapy).He is experienced in combined modality therapy, adjuvant radiotherapy, base pair mismatch, cell cycle, and DNA damage with research support since 1980 from the U.S. National Cancer Institute.
Education & Training
- Brown UniversityM.A., Ad Eundem, 2011
- Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1977 - 1980
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1977
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1974 - 1976
- University of Rochester School of Medicine and DentistryClass of 1974
- University of RochesterM.S., Radiation Biology, 1974
- St. John Fisher CollegeB.S., 1969
Certifications & Licensure
- FL State Medical License 2022 - 2025
- MA State Medical License 1976 - 2024
- RI State Medical License 2009 - 2024
- OH State Medical License 1998 - 2016
- IL State Medical License 1993 - 1999
- WI State Medical License 1987 - 1999
- MD State Medical License 1982 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- American Board of Radiology Therapeutic Radiology
- Join now to see all
Awards, Honors, & Recognition
- Fellow, American Society of Therapeutic Radiology and Oncology American Society of Therapeutic Radiology and Oncology, 2014
- Director's Service Award National Cancer Institute, 2012
- Master of Arts,ad eundem Brown University, 2011
- Join now to see all
Clinical Trials
- Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis Start of enrollment: 2013 May 01
- Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- A case report of typhlitis during novel use of ropidoxuridine-capecitabine-radiotherapy for treatment-naïve rectal cancer.Charles A Kunos, Richard Piekarz, Jerry M Collins, Timothy J Kinsella> ;Cancer Chemotherapy and Pharmacology. 2023 Aug 1
- Editorial: 365 days of progress in radiation oncology.Timothy J Kinsella> ;Frontiers in Oncology. 2023 Jan 1
- 2 citationsClinical Study of Using Biometrics to Identify Patient and Procedure.Jason W. Sohn, Haksoo Kim, S. B. Park, Soyoung Lee, James I. Monroe, Thomas B. Malone, Timothy J. Kinsella, Min Yao, Charles A. Kunos, Simon S. Lo, Robert Shenk, Mitch...> ;Frontiers in Oncology. 2020 Dec 1
- Join now to see all
Journal Articles
- Paclitaxel poliglumex, temozolomide and radiation for newly diagnosed high-grade glioma: A Brown University Oncology Group phase II studyJeyapalan S, Boxerman J, Donahue J, Goldman M, Kinsella, TJ, DiPetrillo T, Evans D, Elinzano H, Constantinou M, Stopa E, Puthawala MY, Cielo D, Santaniello A, Oyelese ..., Amer J Clin Oncol, 1/13/2013
- Developing an in silico model of the modulation of base excision repair (BER) using methoxyamine for more targeted cancer therapeuticsGurkan-Cavusoglu E, Avadan S, Liu L, Kinsella TJ, Loparo KA, IET Systems Biology, 1/1/2013
- Quantitative analysis of the effects of combined iododeoxyuridine (IUdR) and ionizing radiation treatment on the cell cycle dynamics of DNA mismatch repair deficient c...Gurkan-Cavusoglu E, Schupp JE, Kinsella TJ, Loparo KA, IET Systems Biology, 1/1/2013
- Join now to see all
Books/Book Chapters
Other
- "Oncology: An Evidence Based Approach. Springer-Verlag, New York, New York"Chang AE, Gantz PA, Hayes DG, Kinsella TJ, Pass HI, Schiller J, Stone RM, Strecher V (editors)
1/1/2005 - "Management of Metastatic Disease to the Musculoskeletal System, Quality Medical Publishing"Heiner JP, Kinsella TJ, Zdeblick TA (editors)
1/1/2001
Grant Support
- Clinical Development of IPdR for RadiosensitizationNIH/NCI SBIR Fast Track Phase 1-2 Contract2014–Present
- Modeling of DNA Mismatch Repair to improve cancer therapeuticsNIH/NCI2009–2011
- Complex Systems &Control Of Mmr-Deficient CellsNational Cancer Institute2004–2008
- Human Tumor Radiosensitization By IUDR And IpdrNational Cancer Institute2003–2005
- Mismatch Repair Defects And Human Tumor RadiosensitizatiNational Cancer Institute2000–2003
- Human Tumor Radiosensitization By IUDR And IpdrNational Cancer Institute2002
- Clinical Phase I Testing With Phthalocyanine For Skin MalignanciesNational Cancer Institute1999–2002
- Radiosensitization By Halogenated Thymidine AnalogsNational Cancer Institute1998–2000
- Tumor Cell Kinetics And S-Phase SensitizationNational Cancer Institute1994–1996
- Growth Factor Alteration Of Radiation Response In TumorsNational Cancer Institute1990–1993
- Radiation And Chemosensitization With IododeoxyuridineNational Cancer Institute1990–1992
Committees
- Member, NIAID Scientific Review; Development of Medical Countermeasures for Post-Exposure from a Radiation/Nuclear Incident 2013 - 2013
- Reviewer, Pancreatic Cancer Action Network, American Association for Cancer Research Innovation Grants 2011 - 2014
- Member, Board of Scientific Advisors, National Cancer Institute 2007 - 2012
- Member, Scientific Advisory Board, Integrative Cancer Biology Program, MIT 2007 - 2011
- Member, Radiation Discipline Working Group, NASA 2003 - 2005
- Member, External Advisory Committee, Data and Safety Monitoring, Amer College of Surgeons Oncology Group 2000 - 2005
- Member, Radiation Study Section, NIH 1998 - 2001
- Member, Board of Scientific Counselors, National Cancer Institute 1997 - 2001
- Member, Advisory Board to New Approaches to Brain Tumor Therapy, Johns Hopkins/NCI 1995 - 2003
- Member, Extramural Advisory Board, Univ of Arizona Cancer Center 1995 - 1998
- Member, External Advisory Board, Johns Hopkins Oncology Center 1993 - 1999
- Member, External Advisory Board, Sylvester Cancer Center, Univ of Miami 1990 - 1994
- Chairman, Radiation Therapy Committee, Eastern Cooperative Oncology Group 1990 - 1992
- Member, Advisory Committee on Research, Alberta (Canada) Cancer Board 1989 - 1995
- Chairman, Chemical and Biological Modifiers Committee, Radiation Therapy Oncology Group 1989 - 1994
- Member, Radiation Study Section, NIH 1983 - 1987
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- Emma Pendleton Bradley HospitalRiverside, Rhode Island
- Miriam HospitalProvidence, Rhode Island
- Newport HospitalNewport, Rhode Island
- Rhode Island HospitalProvidence, Rhode Island
- Women & Infants Hospital of Rhode IslandProvidence, Rhode Island
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: